<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Cynata Therapeutics Kicks Off Patient Enrollment
Image Overlay - Cynata Therapeutics Kicks Off Patient Enrollment

Cynata Therapeutics Kicks Off Patient Enrollment

September 14, 2020

Cynata Therapeutics Kicks Off Patient Enrollment

Biotech company Cynata Therapeutics has begun enrolling patients in their mesenchymal COVID-19 (MEND) trial. The study will explore the efficacy of mesenchymal stem cells in adults diagnosed with severe cases of the virus. “MSCs represent a very promising therapeutic approach to a range of important diseases,” commented company CEO Ross MacDonald. Yourway can transport, store, and distribute even the most challenging drug products, making us the ideal logistics partner provider for all clinical trial needs.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?